Cell-Based Therapy of Cardiovascular Diseases
A special issue of Cells (ISSN 2073-4409). This special issue belongs to the section "Cells of the Cardiovascular System".
Deadline for manuscript submissions: closed (1 December 2022) | Viewed by 12024
Special Issue Editors
Interests: heart disease; cardiovascular; diabetes; molecular and cellular therapeutics; stem cells
Special Issues, Collections and Topics in MDPI journals
Special Issue Information
Dear Colleagues,
Despite advances in medicine, cardiovascular diseases (CVDs) are still the leading cause of death worldwide. According to WHO key facts, about 17.9 million people died from CVDs in 2019, representing 32% of all global deaths (https://www.who.int/news-room/fact-sheets/detail/cardiovascular-diseases-(cvds)#:~:text=Key%20facts,to%20heart%20attack%20and%20stroke). The development of stem cell biology has enabled cell-based therapy as a promising approach to promote the repair of injured tissue and replenish new and functional cells.
In this Special Issue, we invite cardiologists and cell and developmental biologists to submit research on the strategies to boost and improve our understanding of the mechanism of cell-based therapy for the treatment of cardiovascular diseases. Topics include but are not limited to pluripotent stem cells, multipotent stem cells, and progenitor cells and their derivatives, including nanovesicles and exosomes, novel cellular delivery approaches and monitoring modality, preclinical studies, etc. We hope this Special Issue will provide new insights into understanding the key factors promoting cell-based therapy efficacy, attesting new cellular or molecular interventions, and promoting novel cellular therapeutic strategies for the treatment of cardiovascular diseases.
Dr. Lei Ye
Prof. Dr. Feng Cao
Guest Editors
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Cells is an international peer-reviewed open access semimonthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2700 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
Keywords
- heart diseases
- stem cell biology
- cell transfer therapy
- tissue engineering
- nanomedicine
- cell derivatives
Benefits of Publishing in a Special Issue
- Ease of navigation: Grouping papers by topic helps scholars navigate broad scope journals more efficiently.
- Greater discoverability: Special Issues support the reach and impact of scientific research. Articles in Special Issues are more discoverable and cited more frequently.
- Expansion of research network: Special Issues facilitate connections among authors, fostering scientific collaborations.
- External promotion: Articles in Special Issues are often promoted through the journal's social media, increasing their visibility.
- e-Book format: Special Issues with more than 10 articles can be published as dedicated e-books, ensuring wide and rapid dissemination.
Further information on MDPI's Special Issue polices can be found here.